WallStSmart

Bioceres Crop Solutions Corp (BIOX)vsScotts Miracle-Gro Company (SMG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Scotts Miracle-Gro Company generates 995% more annual revenue ($3.48B vs $318.16M). SMG leads profitability with a 2.1% profit margin vs -17.7%. SMG appears more attractively valued with a PEG of 0.81. SMG earns a higher WallStSmart Score of 48/100 (D+).

BIOX

Hold

46

out of 100

Grade: D+

Growth: 5.3Profit: 2.0Value: 4.7Quality: 2.5
Piotroski: 3/9Altman Z: 0.51

SMG

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 5.5Value: 5.3Quality: 6.5
Piotroski: 5/9Altman Z: 1.90
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BIOX.

SMGSignificantly Overvalued (-17.4%)

Margin of Safety

-17.4%

Fair Value

$57.24

Current Price

$56.47

$0.77 premium

UndervaluedFair: $57.24Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BIOX2 strengths · Avg: 9.0/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

SMG2 strengths · Avg: 9.0/10
Debt/EquityHealth
-10.1310/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.818/10

Growing faster than its price suggests

Areas to Watch

BIOX4 concerns · Avg: 3.0/10
PEG RatioValuation
1.954/10

Expensive relative to growth rate

Market CapQuality
$26.75M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-359.8%2/10

ROE of -359.8% — below average capital efficiency

SMG4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.1%4/10

1.1% revenue growth

Altman Z-ScoreHealth
1.904/10

Grey zone — moderate risk

Profit MarginProfitability
2.1%3/10

2.1% margin — thin

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : BIOX

The strongest argument for BIOX centers on Price/Book, EPS Growth.

Bull Case : SMG

The strongest argument for SMG centers on Debt/Equity, PEG Ratio. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : BIOX

The primary concerns for BIOX are PEG Ratio, Market Cap, Piotroski F-Score. Debt-to-equity of 3.76 is elevated, increasing financial risk.

Bear Case : SMG

The primary concerns for SMG are Revenue Growth, Altman Z-Score, Profit Margin. Thin 2.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

BIOX profiles as a turnaround stock while SMG is a value play — different risk/reward profiles.

SMG carries more volatility with a beta of 1.81 — expect wider price swings.

SMG is growing revenue faster at 1.1% — sustainability is the question.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SMG scores higher overall (48/100 vs 46/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bioceres Crop Solutions Corp

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Bioceres Crop Solutions Corp.

Scotts Miracle-Gro Company

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Scotts Miracle-Gro Company manufactures, markets, and sells lawn and garden products to consumers in the United States and internationally. The company is headquartered in Marysville, Ohio.

Visit Website →

Want to dig deeper into these stocks?